Fact CheckerSign in

NCT06963840Active, not recruitingPhase 2

Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome

Source: ClinicalTrials.gov · Last updated 29 Aug 2025

Brief summary (registry, in English)

Theronomic Ova-All Care is a tribiotic health product aimed at improving ovarian health in people with polycystic ovarian syndrome (PCOS). In this study, a total of 16 participants with PCOS diagnosed by a gynaecologist will be invited to take Ova-All Care, two capsule once a day, for 12 weeks. Biomarkers of ovarian health will be measured at baseline, four weeks after the start of the intervention, and at the end of the intervention.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
16 (actual)
First submitted
30 Apr 2025
Start date
9 May 2025
Primary completion date
Aug 2025
Lead sponsor
Wellizen Australia
NCT number
NCT06963840

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 16
  • From 9 May 2025 to the primary completion date, Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of contraceptives, hormone replacement therapy (HRT), immunosuppressants and other drugs that affect ovarian function in the past 3 months.

Other illness

  • Thyroid disease or hyperprolactinemia
  • Liver and kidney dysfunction, autoimmune diseases (such as systemic lupus erythematosus), malignant tumors, mental illness

Other

  • Pregnancy, lactation;
  • Uterine amenorrhea (such as intrauterine adhesions)
  • Smokers (\>5 cigarettes per day), alcoholics;
  • Unable to cooperate with follow-up or refuse to sign informed consent.

Who the study is looking for

  • Women aged 18-40 years
  • Previous diagnosis of PCOS by a gynaecologist
  • Able to take body temperature every day for 12 weeks
  • Able to attend the testing centre every 4 weeks
  • Able to complete online questionnaires

Age in the registry: 18 years to 40 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pony Testing Centre
Coordinator of this site? Confirm its status
SuzhouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.